NCT03222245View on ClinicalTrials.gov

The Effect of Injectable Therapies on Quality of Life in Diabetes

CompletedOBSERVATIONAL

Enrollment

256

Participants

Timeline

Start Date

June 30, 2017

Primary Completion Date

September 1, 2022

Study Completion Date

September 1, 2022

Conditions

Diabetes

Trial Locations (1)

PO6 3LY

Portsmouth Hospital NHS Trust, Portsmouth

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

AstraZeneca

INDUSTRY

lead

Portsmouth Hospitals NHS Trust

OTHER_GOV